CCM Investment Advisers’s Boston Scientific BSX Stock Holding History

CCM Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,181	Closed	-$213K	–	92
2025 Q3	$213K	Buy	+2,181	New	+$226K	0.02%	85

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CCM Investment Advisers's BSX Position: Q4 2025 in Review

CCM Investment Advisers sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,181 shares — an estimated $213K sold.

CCM Investment Advisers first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $213K in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

CCM Investment Advisers reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
CCM Investment Advisers sold 2,181 Boston Scientific shares in Q4 2025, an estimated $213K.
CCM Investment Advisers first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
CCM Investment Advisers's Boston Scientific position peaked at $213K in Q3 2025.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on CCM Investment Advisers's 13F filing for Q4 2025, filed 12 Jan 2026.